Jet Lag Therapy Market Size, Share, Growth, Trends, and Global Industry Analysis: By Type (Prescription Drugs, Melatonin, Herbal & Natural Products, and Other), By End User (Business Travelers, Cabin Crew, Athletes, and Seasonal Travelers), and Region Forecast 2019-2030

Jet Lag Therapy Market size was valued at US$ 476.2 million in 2023 and is poised to grow at a CAGR of 4.7% from 2024-2030. When the body is forced to adjust to a new time zone, it experiences a variety of symptoms known as jet lag. The complex combination of many physiologic, psychological, and environmental elements that develop during a specific trip and accumulate throughout a season makes up for travel fatigue and exhaustion. Jet lag has been noted in pilots, fliers, flight attendants, medical professionals, and sports. Numerous travelers traveling across several countries might experience physiologic distress and a complex array of mental and physical symptoms. The detrimental consequences of jet lag on a person's performance and well-being are ignored in society. Additionally, there are restrictions on the therapies that are now accessible due to the difficulty of the primary physiologic parameter that directs jet lag therapy. A typical issue for many people who fly is jet lag. There is currently no accepted classification for this illness.

However, most studies include exhaustion, daytime drowsiness, trouble concentrating, memory issues, weakness, and loss of energy after a long journey as symptoms. In most cases, jet lag illness is transient and doesn't require medical intervention. Usually, the disease gets better within a few days, however, occasionally, the symptoms persist for longer. A doctor could, however, suggest medicine or light treatment if a passenger on an airplane complains of jet lag all the time. The development of safe and efficient wearable technology increased end-user compliance, the absence of significant drawbacks, and the rising number of passengers worldwide each year are the favorable aspects most likely to fuel the extension in the market size in the future. Despite fierce competition in the market across Europe and North America, future market growth is expected to be most pronounced in China, Japan, India, Mexico, Brazil, and other emerging economies where market penetration is significantly lower than in developed economies. The adoption of Jet Lag Therapy products is hindered by limited disease knowledge, expensive product costs, a weak economy, and unfavorable insurance systems in underdeveloped nations, thus acting as the main restraining factors in the market growth in the market forecast.

Key Developments

• In June 2022, SleepScore Labs, the company behind the science of sleep improvement, presented fourteen new findings at SLEEP 2022 in Charlotte, North Carolina, the annual meeting of the Associated Professional Sleep Societies, LLC (APSS). SleepScore’s scientific findings cover topics ranging from social jetlag and BMI, aging and chronotypes, and more, all derived from over 90 million hours of SleepScore’s proprietary longitudinal sleep data measured using SleepScore’s leading non-contact sleep technology.